takeda pharmaceutic-sp adr (TKPYY) Key Developments
Takeda Pharmaceutical Co. Consolidate its U.S. Vaccine Operations in Boston/Cambridge Area; Closes Facilities in Madison, Fort Collins, Bozeman and Deerfield, Illinois
Jul 18 15
Takeda Pharmaceutical Co. announced that it is consolidating its U.S. vaccine operations in the Boston/Cambridge area.
The company closing facilities in Madison; Fort Collins, Colorado; Bozeman, Montana; and Deerfield, Illinois.
Takeda Pharmaceutical Company Limited Submits New Drug Application for ixazomib for Patients with Relapsed/Refractory Multiple Myeloma
Jul 14 15
Takeda Pharmaceutical Company Limited announced that a new drug application (NDA) has been submitted to the United States (U.S.) Food and Drug Administration (FDA) for ixazomib, an investigational oral proteasome inhibitor for the treatment of patients with relapsed and/or refractory multiple myeloma. The NDA submission was based on the pivotal Phase 3 trial TOURMALINE-MM1, an international, randomized, double-blind, placebo controlled clinical trial of 722 patients designed to evaluate the superiority of ixazomib plus lenalidomide and dexamethasone over placebo plus lenalidomide and dexamethasone in adult patients with relapsed and/or refractory multiple myeloma. Patients continue to be treated in this trial and evaluated for long-term outcomes.
Takeda Pharmaceutical Company Limited Announces Executive Appointments
Jun 26 15
Takeda Pharmaceutical Company Limited announced the appointment of Yasuchika Hasegawa as Director, Chairman of the Board from his previous position Representative Director, Chairman of the Board. The company also appointed Andrew Plump, M.D., Ph.D. as Director, Chief Medical and Scientific Officer from his previous position Corporate Officer and Yasuhiko Yamanaka as Corporate Auditor from his previous position Managing Director.
Takeda Announces the Resignation of CFO François-Xavier Roger
Jun 24 15
Takeda Pharmaceutical Company Limited announced that François-Xavier Roger has resigned effective June 26, 2015 to become chief financial officer of Nestlé S.A.
Takeda Pharmaceutical Company Limited Presents at BIO International Convention 2015, Jun-17-2015 10:15 AM
Jun 11 15
Takeda Pharmaceutical Company Limited Presents at BIO International Convention 2015, Jun-17-2015 10:15 AM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States.